Keyphrases
Metastasis
100%
Non-small Cell Lung Cancer Patients
100%
Metabolic
100%
Coefficient of Variation
100%
F-18 Fluorodeoxyglucose Positron Emission Tomography
100%
Tumor Heterogeneity
100%
Heterogeneity Analysis
100%
Positron Emission Tomography Combined with Computed Tomography
100%
Mediastinal Lymph Node Metastasis
100%
Metabolic Heterogeneity
80%
Primary Tumor
60%
Non-small Cell Lung Cancer (NSCLC)
40%
Prediction Accuracy
20%
Therapeutic Strategies
20%
Tumor Mass
20%
Optimal Cutoff
20%
Newly Diagnosed
20%
Higher Coefficients
20%
Intraoperative CT
20%
Metabolic Parameters
20%
Conventional Imaging
20%
Surgical Specimen
20%
Complementary Role
20%
F-18 Fluorodeoxyglucose
20%
Pathological Outcomes
20%
Mediastinal Metastasis
20%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Computer Assisted Tomography
100%
Metastatic Carcinoma
100%
Fluorodeoxyglucose F 18
100%
Lymph Node Metastasis
100%
Positron Emission Tomography
100%
Mediastinal Lymph Node
100%
Tumour Heterogeneity
100%
Primary Tumor
60%
Sensitivity and Specificity
20%
Conventional Imaging
20%
Biopsy Technique
20%
Mediastinum Metastasis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Non Small Cell Lung Cancer
100%
Lymph Node Metastasis
100%
Fluorodeoxyglucose F 18
100%
Primary Tumor
60%
Mediastinum Metastasis
20%